Include All CSL Behring Country Sites
About Seqirus Worldwide
With cutting-edge facilities, technologies and technical expertise, Seqirus will be a reliable supplier of seasonal influenza vaccine with the ability to rapidly respond to pandemic threats.
Read More >
Welcome to Seqirus
In July 2015, bioCSL and the influenza vaccines of Novartis joined forces to create Seqirus, now the second ...
Seqirus receives FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older
Seqirus announced today that the US Food and ...
Seqirus Presents Integrated Analyses for Trivalent Adjuvanted Seasonal Influenza Vaccine for Young Children
Seqirus today announced results of two data ...
Seqirus is first-to-market with shipment of seasonal influenza vaccines to the US for the 2016-2017 season
The Seqirus portfolio for this season will ...
© 2017 Seqirus